Jubilant HollisterStier Wins Parenteral Contracts

Jubilant HollisterStier’s Contract Manufacturing & Services division, a subsidiary of Jubilant Life Sciences, has recently secured more than $100 million in contracts with pharmaceutical companies for the commercial manufacture of multiple sterile parenteral products.

Jubilant HollisterStier’s Contract Manufacturing & Services division, a subsidiary of Jubilant Life Sciences, has recently secured more than $100 million in contracts with pharmaceutical companies for the commercial manufacture of multiple sterile parenteral products. These awards expand existing relationships and will be executed across both parenteral manufacturing locations in Spokane WA, and Montreal, Canada. The commercial technology transfer efforts are expected to begin in 2013.
 
“We are excited to expand our existing strategic commercial relationships, and will bring forward our capabilities in manufacturing excellence, rigorous quality oversight and project management to support a smooth and timely transfer to our manufacturing locations,” said Marcelo Morales, Jubilant HollisterStier’s chief executive officer.